Browse > Article
http://dx.doi.org/10.3904/kjim.2015.30.6.789

Time to learn from the past and prepare for the future in Helicobacter pylori eradication  

Bang, Chang Seok (Department of Internal Medicine, Hallym University College of Medicine)
Baik, Gwang Ho (Department of Internal Medicine, Hallym University College of Medicine)
Publication Information
The Korean journal of internal medicine / v.30, no.6, 2015 , pp. 789-791 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-975.   DOI
2 Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-340.   DOI
3 Lim SH, Kwon JW, Kim N, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol 2013;13:104.   DOI
4 Lee JY, Kim N. Future trends of Helicobacter pylori eradication therapy in Korea. Korean J Gastroenterol 2014;63:158-170.   DOI
5 Kim NY. Helicobacter pylori. Seoul; Daehanuihak, 2015.
6 Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-141.   DOI
7 McColl KE. Clinical practice: Helicobacter pylori infection. N Engl J Med 2010;362:1597-1604.   DOI
8 Cheung DY, Kim TH. Helicobacter pylori in human stomach: can it be called mutualism or a disease? Korean J Gastroenterol 2012;59:329-337.   DOI
9 Kim SG, Jung HK, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol 2013;62:3-26.   DOI
10 Jo Y. Decreased eradication rates of Helicobacter pylori and problem solving. Korean J Gastroenterol 2014;63:63-65.   DOI
11 Gong EJ, Yun SC, Jung HY, et al. Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change? J Korean Med Sci 2014;29:704-713.   DOI
12 Kim SE, Park MI, Park SJ, et al. Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy. Korean J Intern Med 2015;30:801-807.   DOI
13 Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report. Gut 2012;61:646-664.   DOI
14 Lee JW, Kim N, Kim JM, et al. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013;18:206-214.   DOI
15 Hwang TJ, Kim N, Kim HB, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 2010;44:536-543.
16 De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin- resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006;144:94-100.   DOI
17 Jung MK, Lee JK, Heo J, Kang EJ, Lee YR. The effect of concomittent therarpy and quadruple therapy for patients who had 23S ribosomal ribonucleic acid mutated Helicobacter pylori in Daegu and Kyoungpook area. Korean J Helicobacter Up Gastrointest Res 2014;14:249-254.   DOI
18 Graham DY. Editorial: avoiding unethical Helicobacter pylori clinical trials: susceptibility-based studies and probiotics as adjuvants. Helicobacter 2015;20:321-325.   DOI